Meta Platforms plans to introduce advertisements to its social media platform Threads next year, the Information reported on ...

J.P. Morgan analyst Lisa Gill maintained a Buy rating on CVS Health (CVS – Research Report) yesterday and set a price target of $80.00. The company’s shares closed yesterday at $54.03. Gill covers the ...

Charles Rhyee, an analyst from TD Cowen, maintained the Buy rating on CVS Health (CVS – Research Report). The associated price target was ...

Joyner’s comments were his first made publicly since he was promoted less than a month ago to replace Karen S. Lynch, who stepped down. CVS Health has struggled to control costs in its Aetna health ...

CVS Health Corp. faces continued challenges in its insurance business, prompting the company to shake up its management ranks in a bid to get back on track. Shares of the pharmacy and healthcare ...

Nina Dobrev and Shaun White are engaged! The Olympic snowboarder popped the question to Dobrev in October after more than four years of dating, the couple revealed to Vogue in an interview ...

Cigna subsidiary Evernorth Health Services, Elevance Health subsidiary Carelon and Aetna parent company CVS Health have made big plays into the $400 billion market for medications that are too ...

In this article, we are going to take a look at where CVS Health Corporation (NYSE:CVS) stands against the other high growth retail stocks. US retail sales increased solidly in September ...

Quarter Pounders are headed back to McDonald’s restaurants in Colorado after an E. coli outbreak, but a food safety expert said investigators are only beginning their work. The Colorado ...

In this article, we are going to take a look at where CVS Health Corporation (NYSE:CVS) stands against the other most profitable value stocks to invest in. Value investing is essentially focused ...

CVS Health surprised Wall Street with an unexpected change in corporate leadership last month when it named David Joyner its newest president and CEO. Joyner replaces Karen Lynch, who had served as ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...